Oct 2026· Metabolites· Vol 16, pp. 778· 0 citations· 27 references
TL;DR
Older age and higher pre-index-amputation CRP levels were independently associated with membership in the re-amputation group, and these ratios were not independently associated after adjustment for age and CRP.
Abstract
Background and Objectives: Re-amputation is an important adverse outcome of diabetic foot disease. This study compared age and preoperative inflammatory parameters between patients with and without subsequent re-amputation and examined their adjusted associations with re-amputation group membership. Materials and Methods: The records of 206 patients treated between 2013 and 2024 were reviewed retrospectively, with 103 patients included in each group. Laboratory parameters obtained before the index amputation were analyzed in both groups. Between-group comparisons were performed using the Mann–Whitney U test. Three exploratory binary logistic regression models included age and C-reactive protein (CRP), together with the neutrophil-to-lymphocyte ratio (NLR), monocyte-to-lymphocyte ratio (MLR), or platelet-to-lymphocyte ratio (PLR). The regression and ROC analyses were based on 197 complete cases. Results: Patients in the re-amputation group were older and had higher WBC, neutrophil, monocyte, CRP, NLR, MLR, and PLR values and lower lymphocyte values. In the primary model, age (adjusted OR = 1.034, 95% CI: 1.010–1.058; p = 0.006) and CRP (adjusted OR = 1.006 per 1 mg/L, 95% CI: 1.003–1.010; p = 0.001) were independently associated with re-amputation group membership, whereas NLR was not (p = 0.834). Neither MLR (p = 0.176) nor PLR (p = 0.446) was independently associated in the alternative models. Individual-marker AUCs ranged from 0.604 to 0.647, indicating limited discrimination. Conclusions: Older age and higher pre-index-amputation CRP levels were independently associated with membership in the re-amputation group. Although NLR, MLR, and PLR differed between groups, these ratios were not independently associated after adjustment for age and CRP. The limited discriminatory performance and data-derived cutoff values require validation in larger, independent cohorts.
Diabetic foot ulcers frequently lead to amputation, and early risk identification remains challenging. Although the neutrophil-to-lymphocyte ratio (NLR) may predict amputation risk, supporting evidence remains limited. This study evaluated the association between NLR and amputation risk in patients with diabetic foot (...
Rui-Bin Feng, Cairui Chen, Qi-Kai Hua· International Journal of Low...· 0 citations
PIV and FAR were independently associated with amputation risk in patients with LEAD who underwent EVT and the addition of these biomarkers to established clinical variables provided incremental prognostic value and may offer additional prognostic information for risk stratification.
Jing Li, Zuo-Yi Yao, Lu Tang et al.· Clinical and applied thrombo...· 0 citations
Background This study aimed to comprehensively evaluate the association of twelve inflammation-related biomarkers with amputation level (major vs. minor) in diabetic foot ulcer (DFU) patients undergoing amputation, with particular focus on identifying the strongest associated factor and exploring differences between ab...
Objectives: This study aimed to evaluate the association between laboratory-based metabolic, inflammatory, and nutritional markers and in-hospital mortality among patients aged 65 years and older with diabetic foot ulcers. Materials and Methods: The retrospective study included 110 patients who were followed up for dia...
K. Erdogan, Arife Polat Düzgün· Bolu Abant Izzet Baysal Univ...· 0 citations
Background Diabetic foot infection (DFI) is a major cause of non-traumatic lower-limb amputation and is associated with poor survival outcomes. Identifying therapies that reduce progression to amputation is critical. Objective To evaluate the association between statin therapy and risk of amputation in patients with DF...
Jana Abdallah, M. Ababneh, A. Jarab et al.· Frontiers in Endocrinology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.